EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallbericht

Pericarditis related to post-acute COVID infection: A case report and review of the literature

Nhu Ngoc Nguyen, Pierre Dudouet, Catherine Dhiver, Philippe Gautret iD

Acta Microbiologica et Immunologica Hungarica · 2023

DOI: 10.1556/030.2023.02055 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Acta Microbiologica et Immunologica Hungarica, 2023. Verfasst von Nhu Ngoc Nguyen und 3 weiteren Autor:innen. Beteiligte Einrichtung: 1Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France. Hauptthemen laut MEDLINE: COVID-19, Pericarditis. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 28 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cardiovascular involvement has been described in acute and recovered COVID-19 patients. Here, we present a case of symptomatic pericarditis with persistent symptoms for at least six months after the acute infection and report 66 published cases of pericarditis in discharged COVID patients. Patient mean age ± SD was 49.7 ± 13.3 years, ranging from 15 to 75 years and 57.6% were female. A proportion of 89.4% patients reported at least one comorbidity, with autoimmune and allergic disorders, hypertension and dyslipidaemia, as the most frequent. Only 8.3% of patients experienced severe symptoms of acute COVID-19. The time between acute COVID and pericarditis symptoms varied from 14 to 255 days. Chest pain (90.9%), tachycardia (60.0%) and dyspnoea (38.2%) were the most frequent symptoms in post-acute pericarditis. A proportion of 45.5% and 87% of patients had an abnormal electrocardiogram and abnormal transthoracic ultrasound, respectively. Colchicine combined with non-steroidal anti-inflammatory drug (NSAID) or acetylsalicylic acid (aspirin) were prescribed to 39/54 (72%) patients. Of them, 12 were switched to corticosteroid therapy due to non-response to the first-line treatment. Only 6 patients had persisting symptoms and were considered as non-respondent to therapy. Our report highlights that pericarditis should be suspected in COVID-19 patients with persistent chest pain and dyspnoea when pulmonary function is normal. Treatment with non-steroidal anti-inflammatory and colchicine is usually effective but corticosteroids are sometimes required.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

COVID-19PericarditisHumansFemaleMaleAnti-Inflammatory Agents, Non-SteroidalAspirinColchicineChest Pain

Stichwörter der Autor:innen

COVID-19SAR-CoV-2long COVIDpericardial effusionpericarditispost-acute COVID

Substanzen

Anti-Inflammatory Agents, Non-SteroidalAspirinColchicine

Autor:innen und Institutionen

  • 1Aix Marseille University, IRD, AP-HM, SSA, VITROME, Marseille, France.
  • 2IHU-Méditerranée Infection, Marseille, France.

ORCID-Profile: Philippe Gautret

Zitieren

APA

Nguyen, N. N., Dudouet, P., Dhiver, C., & Gautret, P. (2023). Pericarditis related to post-acute COVID infection: A case report and review of the literature. Acta Microbiologica et Immunologica Hungarica. https://doi.org/10.1556/030.2023.02055

Vancouver

Nguyen NN, Dudouet P, Dhiver C, Gautret P. Pericarditis related to post-acute COVID infection: A case report and review of the literature. Acta Microbiologica et Immunologica Hungarica. 2023. doi:10.1556/030.2023.02055

BibTeX
@article{Nguyen2023,
  author = {Nguyen, Nhu Ngoc and Dudouet, Pierre and Dhiver, Catherine and Gautret, Philippe},
  title = {Pericarditis related to post-acute COVID infection: A case report and review of the literature},
  journal = {Acta Microbiologica et Immunologica Hungarica},
  year = {2023},
  doi = {10.1556/030.2023.02055}
}
Kostenlos starten →